Given the prevalence of glycans on the outer layer of cancer cells and the distinct expression of certain glycan structures such as the Tn and STn antigens across various tumor types, these molecules hold potential as targets for disease diagnosis, prognosis assessment, and drug delivery. This evidence concerns the gene EEF1A2 and cancer.